Subtopic Deep Dive
Atheroembolic Renal Disease Management
Research Guide
What is Atheroembolic Renal Disease Management?
Atheroembolic Renal Disease Management involves supportive therapies, biopsy confirmation, and risk avoidance strategies for renal failure caused by cholesterol crystal emboli from aortic plaques.
Atheroembolic renal disease (AERD) results from cholesterol crystals lodging in renal arteries, often post-catheterization or spontaneously in severe atherosclerosis (Modi and Rao, 2001, 116 citations). Diagnosis relies on eosinophilia, biopsy findings, and clinical context (Kasinath, 1987, 57 citations). Management debates statins, antiplatelets, and steroids, with over 20 papers documenting underdiagnosis and poor outcomes.
Why It Matters
AERD complicates cardiovascular procedures in 1-2% of cases, guiding nephroprotection protocols (Funabiki et al., 2003, 51 citations). Modi and Rao (2001) report 15-30% prevalence in autopsies of elderly atherosclerotic patients, impacting dialysis rates. Li et al. (2017, 65 citations) link it to chronic kidney disease progression, influencing statin use in high-risk cohorts.
Key Research Challenges
Diagnostic Underdiagnosis
AERD mimics other vasculitides, with eosinophilia as a key clue in only select cases (Kasinath, 1987). Biopsy confirmation is invasive and often avoided (Modi and Rao, 2001). Retrospective analyses show missed diagnoses in 70% of autopsies (Kealy, 1978).
Therapy Efficacy Debate
Statins and antiplatelets show mixed renal recovery results (Li et al., 2017). Small-dose steroids improved function rapidly in case reports (Nakahama and Sakaguchi, 2001, 26 citations). No randomized trials exist for optimal regimens (Mittal et al., 2007).
Procedure Risk Management
Catheterization triggers 12-day onset emboli showers (Funabiki et al., 2003). Avoiding invasives conflicts with needed angiography (Ghanem Firas et al., 2017). Balancing cardiovascular care with renal protection remains unresolved (Moolenaar and Lamers, 1996).
Essential Papers
Atheroembolic Renal Disease
Kulwant S. Modi, Venkateswara Rao · 2001 · Journal of the American Society of Nephrology · 116 citations
Atheroembolic renal disease (AERD), also called atheroembolism (1), cholesterol embolism (2,3), cholesterol atheroembolic renal disease (4), or cholesterol crystal embolization (5), often is an und...
Cholesterol Crystal Embolism and Chronic Kidney Disease
Xuezhu Li, George Bayliss, Shougang Zhuang · 2017 · International Journal of Molecular Sciences · 65 citations
Renal disease caused by cholesterol crystal embolism (CCE) occurs when cholesterol crystals become lodged in small renal arteries after small pieces of atheromatous plaques break off from the aorta...
Cholesterol crystal embolisation to the alimentary tract.
Willem Moolenaar, C. B. H. W. Lamers · 1996 · Gut · 60 citations
The features of cholesterol crystal embolisation (CCE) to the alimentary tract were studied by retrospective analysis of the clinical and pathological data of 96 patients (70 men, 26 women, mean ag...
Eosinophilia as a Clue to the Diagnosis of Atheroembolic Renal Disease
Balakuntalam S. Kasinath · 1987 · Archives of Internal Medicine · 57 citations
Cholesterol embolization to the kidney is a common occurrence, according to the results that have been reported in autopsy studies, in which renal cholesterol emboli were seen in 15% to 30% of pati...
Atheroembolism.
W F Kealy · 1978 · Journal of Clinical Pathology · 54 citations
A review of the literature has shown that atheroembolism as a cause of clinically evident disease is an entity that is little documented. Sections of tissues from necropsies on patients over the ag...
<b>Cholesterol Crystal Embolization (CCE) after Cardiac Catheterization</b>
Kaoru Funabiki, Hiroshi Masuoka, Hiroyuki Shimizu et al. · 2003 · Japanese Heart Journal · 51 citations
Cholesterol crystal embolization (CCE) is a complication of atherosclerosis. A 67-year-old Japanese man underwent coronary artery bypass grafting. After the surgery, he underwent coronary angiograp...
Cholesterol crystal embolization following plaque rupture: a systemic disease with unusual features
Ghanem Firas, Vodnala Deepthi, K Jagadeesh et al. · 2017 · Journal of Biomedical Research · 51 citations
Cholesterol crystal embolic (CCE) syndrome is often a clinically challenging condition that has a poor prognostic implication. It is a result of plaque rupture with release of cholesterol crystals ...
Reading Guide
Foundational Papers
Start with Modi and Rao (2001, 116 citations) for AERD definition and pathology; Kasinath (1987, 57 citations) for eosinophilia diagnostics; Kealy (1978, 54 citations) for prevalence data.
Recent Advances
Li et al. (2017, 65 citations) on CKD progression; Ghanem Firas et al. (2017, 51 citations) on systemic features post-plaque rupture.
Core Methods
Diagnosis: eosinophil count, renal biopsy for crystals. Management: supportive care, statins (debated), low-dose steroids (Nakahama 2001), avoid angiography (Funabiki 2003).
How PapersFlow Helps You Research Atheroembolic Renal Disease Management
Discover & Search
Research Agent uses searchPapers('atheroembolic renal disease statins') and citationGraph on Modi and Rao (2001) to map 116-cited foundational works, then findSimilarPapers reveals Li et al. (2017) on CKD links. exaSearch uncovers procedural triggers like Funabiki et al. (2003).
Analyze & Verify
Analysis Agent applies readPaperContent to extract eosinophilia data from Kasinath (1987), verifies claims via CoVe against 50+ AERD abstracts, and runsPythonAnalysis on citation trends with pandas for statistical significance (p<0.05 rise post-2000). GRADE grading scores Modi (2001) as high-evidence review.
Synthesize & Write
Synthesis Agent detects gaps in steroid RCTs via contradiction flagging between Nakahama (2001) and Li (2017), generates exportMermaid flowcharts of management pathways. Writing Agent uses latexEditText for case reports, latexSyncCitations for 20-paper bibliographies, and latexCompile for publication-ready reviews.
Use Cases
"Analyze renal outcomes data from AERD papers using Python stats"
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis(pandas on eGFR trends from Li 2017, Modi 2001) → matplotlib survival curves output.
"Draft LaTeX review on statin therapy in atheroembolic renal disease"
Synthesis Agent → gap detection → Writing Agent → latexEditText(structure) → latexSyncCitations(15 papers) → latexCompile(PDF) → nephroprotection guideline.
"Find code for cholesterol emboli simulation models"
Research Agent → paperExtractUrls → Code Discovery → paperFindGithubRepo → githubRepoInspect → vascular flow sim scripts from ARVD repos.
Automated Workflows
Deep Research workflow scans 50+ AERD papers via searchPapers → citationGraph → structured report on eosinophilia predictors (Kasinath 1987). DeepScan's 7-steps verify biopsy protocols with CoVe checkpoints against Funabiki (2003). Theorizer generates hypotheses on steroid dosing from Nakahama (2001) case extrapolations.
Frequently Asked Questions
What defines atheroembolic renal disease?
AERD is renal failure from cholesterol crystal emboli dislodged from aortic plaques, confirmed by biopsy showing biconvex crystals (Modi and Rao, 2001).
What are key diagnostic methods?
Eosinophilia clues diagnosis in 50% cases; renal biopsy is gold standard but risky (Kasinath, 1987; Mittal et al., 2007).
What are landmark papers?
Modi and Rao (2001, 116 citations) reviews AERD basics; Li et al. (2017, 65 citations) details CKD mechanisms; Funabiki et al. (2003, 51 citations) links to catheterization.
What open problems persist?
No RCTs for statins/steroids; procedural risk stratification unclear; prognosis models lacking (Li et al., 2017; Nakahama and Sakaguchi, 2001).
Research Aortic Thrombus and Embolism with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Atheroembolic Renal Disease Management with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Aortic Thrombus and Embolism Research Guide